DOI QR코드

DOI QR Code

Thalamic hemi-chorea: a rare complication after receiving the adenoviral vector-based COVID-19 vaccine: a case report

  • Hamze Shahali (Faculty of Aerospace and Sub-Aquatic Medicine, Aja University of Medical Sciences) ;
  • Ramin Hamidi Farahani (Department of Infectious and Tropical Diseases, Faculty of Medicine, Aja University of Medical Sciences) ;
  • Ali Asgari (Department of Infectious and Tropical Diseases, Faculty of Medicine, Aja University of Medical Sciences) ;
  • Ebrahim Hazrati (Department of Anesthesiology and Critical Care, Trauma Research Center, AJA University of Medical Sciences)
  • Received : 2021.09.07
  • Accepted : 2022.04.30
  • Published : 2022.05.31

Abstract

Lacunar strokes occur when a branch of a large cerebral artery is blocked. The thalamus is often affected, causing uncontrollable motions. A 72-year-old previously healthy man presented with involuntary motions in the right limbs, which were present at rest, and exacerbated during voluntary actions. He had received the first dose of the adenoviral vector-based coronavirus disease 2019 vaccine (ChAdOx1 nCoV-19) 9 days ago. Severe thrombocytopenia and elevated levels of lactate dehydrogenase, ferritin, C-reactive protein, and D-dimer were found, without any evidence of connective tissue disease. Electromyography demonstrated typical choreiform movements, and the brain magnetic resonance imaging indicated a small high signal lesion on the left side of the thalamus. Detection of the immunoglobulin G antibodies against platelet factor 4 in the blood, negative heparin-induced platelet activation (HIPA) test, and positive modified HIPA test confirmed the thalamic stroke due to the vaccine-induced prothrombotic immune thrombocytopenia (VIPIT). He was admitted to the intensive care unit and received nadroparin, sodium ozagrel, edaravone, methylprednisolone, and haloperidol. His hemi-chorea improved gradually over 2 weeks, and he was discharged after 21 days with rehabilitation advice. VIPIT due to the ChAdOx1 nCoV-19 is a novel immune-mediated response that needs clinicians' awareness and further investigations.

Keywords

References

  1. Gore M, Bansal K, Asuncion RM. Lacunar stroke. Treasure Island (FL): StatPearls Publishing; 2021. 
  2. Das AS, Regenhardt RW, Feske SK, Gurol ME. Treatment approaches to lacunar stroke. J Stroke Cerebrovasc Dis 2019;28:2055-78. 
  3. Venkataraman P, Tadi P, Lui F. Lacunar syndromes. Treasure Island (FL): StatPearls Publishing; 2020. 
  4. Gupta N, Pandey S. Post-thalamic stroke movement disorders: a systematic review. Eur Neurol 2018;79:303-14. 
  5. Oldenburg J, Klamroth R, Langer F, et al. Diagnosis and management of vaccine-related thrombosis following AstraZeneca COVID-19 vaccination: guidance statement from the GTH. Hamostaseologie 2021;41:184-9. 
  6. Shahali H, Ghasemi A, Farahani RH, Nezami Asl A, Hazrati E. Acute transverse myelitis after SARS-CoV-2 infection: a rare complicated case of rapid onset paraplegia. J Neurovirol 2021;27:354-8. 
  7. Darvishi M, Shahali H. Overt hematochezia : a rare gastrointestinal presentation in patients with corona virus disease 2019. Med J Armed Forces India 2021;77(Suppl 2):S494-8. 
  8. Schultz NH, Sorvoll IH, Michelsen AE, et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med 2021;384:2124-30. 
  9. Blauenfeldt RA, Kristensen SR, Ernstsen SL, Kristensen CC, Simonsen CZ, Hvas AM. Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine. J Thromb Haemost 2021;19:1771-5.